BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36687242)

  • 1. Survival and Quality of Life (QoL) Enhancing Effect of Surgery in Larynx and Hypopharynx Cancers.
    Varghese BT
    Indian J Surg Oncol; 2022 Dec; 13(4):888-889. PubMed ID: 36687242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcome in patients undergoing surgery for carcinoma larynx and hypopharynx: a follow-up study.
    Varghese BT; Sebastian P; Mathew A
    Acta Otolaryngol; 2009 Dec; 129(12):1480-5. PubMed ID: 19922101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited surgery for cancer of the larynx and hypopharynx: options and consequences.
    Nakayama M; Takahashi H; Yao K; Inagi K; Makoshi T; Nagai H; Okamoto M
    Acta Otolaryngol Suppl; 2002; (547):41-5. PubMed ID: 12212592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization.
    Lukits J; Timár J; Juhász A; Döme B; Paku S; Répássy G
    Otolaryngol Head Neck Surg; 2001 Jul; 125(1):18-22. PubMed ID: 11458208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome following total laryngectomy for cancer.
    Hall FT; O'Brien CJ; Clifford AR; McNeil EB; Bron L; Jackson MA
    ANZ J Surg; 2003 May; 73(5):300-5. PubMed ID: 12752286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 10-Year Study on Larynx Preservation Compared With Surgical Resection in Patients With Locally Advanced Laryngeal and Hypopharyngeal Cancers.
    Su X; He HC; Ye ZL; Zhou DL; Liu Q; Yang XH; Long YK; Tang T; Ma JJ; Xu BH; Chen WC; He CY; Yang AK
    Front Oncol; 2020; 10():535893. PubMed ID: 33178574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of advanced hypopharyngeal carcinoma: systematic review of survival following surgical and non-surgical treatments.
    Habib A
    J Laryngol Otol; 2018 May; 132(5):385-400. PubMed ID: 29891019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic Outcomes After Salvage Laryngectomy for Squamous Cell Carcinoma of the Larynx and Hypopharynx: A Multicenter Retrospective Cohort Study.
    Meulemans J; Debacker J; Demarsin H; Vanclooster C; Neyt P; Mennes T; Vauterin T; Huvenne W; Laenen A; Delaere P; Vander Poorten V
    Ann Surg Oncol; 2021 Mar; 28(3):1751-1761. PubMed ID: 32860174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment results of 99 patients undergoing open partial hypopharyngectomy with larynx preservation.
    Shinozaki T; Hayashi R; Okano W; Tomioka T; Higashino T
    Jpn J Clin Oncol; 2019 Oct; 49(10):919-923. PubMed ID: 31242294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vocal handicap and quality of life after treatment of advanced squamous carcinoma of the larynx and/or hypopharynx.
    Azevedo EH; Montoni N; Gonçalves Filho J; Kowalski LP; Carrara-de Angelis E
    J Voice; 2012 Mar; 26(2):e63-71. PubMed ID: 21724367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Larynx-preserving hybrid surgery with endoscopic laryngopharyngeal surgery and open surgery for cervical esophageal cancer invading pharynx.
    Watanabe A; Taniguchi M; Kimura Y; Kikkawa T; Hosokawa M
    Dis Esophagus; 2020 Dec; 33(12):. PubMed ID: 32350502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinico-radiological Co-relation of Carcinoma Larynx and Hypopharynx: A Prospective Study.
    Nayana VG; Divya GM; Ramachandran K; Muraleedharan Nampoothiri P
    Indian J Otolaryngol Head Neck Surg; 2019 Mar; 71(1):22-28. PubMed ID: 30906708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathomorphological aspects of transoral resection of hypopharyngeal carcinoma with preservation of the larynx. Patient selection, treatment results].
    Glanz H
    Laryngorhinootologie; 1999 Dec; 78(12):654-62. PubMed ID: 10666691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Therapeutic Strategies for Patients with Hypopharyngeal Carcinoma: Oncologic and Functional Outcomes.
    Bozec A; Poissonnet G; Dassonville O; Culié D
    J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Larynx preservation and hypopharyngeal reconstruction in posterior hypopharyngeal wall sqamous cell carcinoma].
    Yan D; Zhang B; Li D; Li Z; Liu W; Xu Z
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 49(7):548-52. PubMed ID: 25257268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial).
    Dietz A; Rudat V; Dreyhaupt J; Pritsch M; Hoppe F; Hagen R; Pfreundner L; Schröder U; Eckel H; Hess M; Schröder M; Schneider P; Jens B; Zenner HP; Werner JA; Engenhardt-Cabillic R; Vanselow B; Plinkert P; Niewald M; Kuhnt T; Budach W; Flentje M
    Eur Arch Otorhinolaryngol; 2009 Aug; 266(8):1291-300. PubMed ID: 18972123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual evaluation of the larynx and hypopharynx during esophagogastroduodenoscopy: a safety and feasibility study.
    Stevens SM; Johnson EA; Pfau PR; Dailey SH
    Surg Endosc; 2015 May; 29(5):1209-15. PubMed ID: 25303903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemipharyngectomy and hemilaryngectomy for pyriform sinus cancer: reconstruction with remaining larynx and hypopharynx and with tracheostomy.
    Barzan L; Comoretto R
    Laryngoscope; 1993 Jan; 103(1 Pt 1):82-6. PubMed ID: 8421425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in the Quality of Life in Oropharyngeal, Laryngeal and Hypopharyngeal Cancer Patients treated with Volumetric Modulated Arc-Based Concomitant Boost Radiotherapy.
    Kannan P; Mukherji A; Saravanan K; Reddy KS; Vivekanandam S; Shamsudheen C; Santhosh V
    Gulf J Oncolog; 2016 May; 1(21):36-45. PubMed ID: 27250886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.